Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 15, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies Advances Dronabinol Therapeutic Equivalence Program Through Purchase Agreement With Noramco

NEW YORK, May 15, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that it has reached a long-term...
April 23, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Secures Additional Funding to Advance Cannabidnoid-Based Clinical Development Program for Multiple Indications

NEW YORK, April 23, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the company has secured...
April 18, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Files Patent Application on Product Formulation Comprised of Cannabinoids With Anti-Bacterial and Anti-Fungal Activities

NEW YORK, April 18, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech), (OTC:AXIM), a world leader in cannabinoid research and development, today announced that the European Patent...
April 03, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Reaches Preliminary Agreement for Distribution of CanChew and MedChew Products Throughout South Korea

NEW YORK, April 03, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that it has...
March 21, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech to Attend BioCentury’s 25th Annual Future Leaders in the Biotech Industry Conference in New York

NEW YORK, March 21, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced that George E....
March 19, 2018 16:15 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotechnologies Reports Year End 2017 Results

NEW YORK, March 19, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTC:AXIM), a world leader in cannabinoid research and development, today announced financial results for...
February 27, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Announces First-Ever Successful Achievement of Proprietary cGMP Extraction and Manufacturing Methods for Pure Cannabinoid Molecules

NEW YORK, Feb. 27, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, today announced the first-ever successful execution...
February 21, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

CBS News Covers AXIM Biotech’s Patent Filing for Controlled-Release Chewing Gum to Provide Treatment for Opioid Addiction

NEW YORK, Feb. 21, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (AXIM® Biotech) (OTCQB:AXIM), a world leader in cannabinoid research and development, today announced that CBS News...
February 06, 2018 10:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Enters Into Distribution Agreement for Proprietary Cannabinoid-Based Nutraceutical Chewing Gum Product CanChew+ Throughout Thailand

NEW YORK, Feb. 06, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM) (“AXIM”), the world leader in cannabinoid research and development, announced today that it has entered into a...
January 23, 2018 09:00 ET | Source: AXIM BIOTECHNOLOGIES, INC

AXIM Biotech Announces Successful Completion of Exploratory Meeting with the Dutch Medicines Evaluation Board on MedChew Rx Program for Treatment of Pain and Spasticity in MS Patients

NEW YORK, Jan. 23, 2018 (GLOBE NEWSWIRE) -- AXIM® Biotechnologies, Inc. (OTC:AXIM), the world leader in cannabinoid research and development, announced today that it has successfully completed an...